Navigation Links
FDA petition would protect public from dangerous drugs
Date:11/14/2007

WASHINGTON---In a petition filed today with the U.S. Food and Drug Administration, an international coalition of scientists and doctors seeks to compel the agency to stem the flood of dangerous drugs reaching American consumers by mandating the use of scientifically superior non-animal testing methods when those alternatives exist.

Petition signatories include a plaintiff in a Vioxx lawsuit who refuses to accept the recently proposed settlement with Merck because she is concerned that misleading animal drug testing will continue to put consumers at risk. After taking Vioxx to cope with pain from a shoulder injury, Nancy Tufford was diagnosed with congestive heart failure. Vioxx, a painkiller that appeared beneficial to the heart in mouse studies, was withdrawn from the market after it was shown to be the likely cause of thousands of fatal cardiac events in people.

Noting a series of similar tragedies in which pharmaceutical products that seemed safe in animal tests injured or killed consumers or participants in clinical trials, the coalition calls on the FDA to emulate a European Union regulation that requires the use of human-centered testing methods, when available. The Mandatory Alternatives Petition, or MAP, lays the groundwork for legal action. If the FDA does not act within six months, the petitioners will consider further action.

Dangerous drugs are killing American consumers because regulators allow drug companies to use misleading animal tests, says coalition spokesman John J. Pippin, M.D., F.A.C.C. The Food and Drug Administration could avert these tragedies by focusing on human-centered methods.

Recent pharmaceutical product testing failures include Mercks HIV vaccine, which appeared safe and effective when tested in monkeys. Subsequently, a large international clinical trial was halted when Mercks new vaccine appeared to increase the risk that a human patient would contract the virus that causes AIDS.

<
'/>"/>
Contact: Jeanne McVey
jeannem@pcrm.org
202-527-7316
Physicians Committee for Responsible Medicine
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Corbett Selected to Host the Only Midwest Global Awards Judging Competition
2. Zipfizz(R) Blows Away Competition
3. Pharmaceutical Product Marketing: Launching Drugs That Outperform the Competition
4. Delaware Court Approves Bioenvision, Genzyme Joint Petition
5. Collegiate Inventors Competition(R) Announces Winners for 2007
6. Collegiate Inventors Competition announces winners for 2007
7. More than 10,000 Medicare Patients in Montana Could Be Hit by Proposed Cuts to Home Oxygen Therapy; Access to Power Wheelchairs Would Also Decrease
8. Would Your Home Receive a Passing Grade in Health Care Check-Up?
9. Voters Deserve to Know: Would Giuliani, McCain, Romney and Thompson Stand with Bush and Veto Childrens Health Care?
10. Does your Child or Spouse have an Eating Disorder? If They Did, Would You Know?
11. Malaria product portfolio would benefit from greater cohesion amongst stakeholders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2015)... 04, 2015 Pricing Healthcare announces ... of one patient receiving care at St. George Surgical ... procedure must be performed by July 15th, 2015, and the ... full up front and forego the filing of insurance claims). ... burdensome every year, and it devastates more and more individuals ...
(Date:5/4/2015)... MT (PRWEB) May 04, 2015 New ... with Care to Care, LLC to manage outpatient advanced ... help New West Medicare ensure its members are provided ... unnecessary radiation. , Working closely with New West Medicare’s ... promoting the safe use of advanced imaging and provide ...
(Date:5/4/2015)... In response to the proposed mammography guidelines from ... Radiology® (SR®) fully aligns itself with organizations such ... the American College Of Surgeons, Susan G. Komen ... College of Radiology (ACR), and Society of Breast ... for women beginning at age 40 in order ...
(Date:5/4/2015)... May 04, 2015 Scanmarket, a leading ... has been included in the just-released Spend Matters “50 ... the Spend Matters " 50 To Know " listing ... of Scanmarket’s commitment to providing comprehensive, easy-to-use strategic sourcing ... Nielsen, “There are many well-established and respected companies on ...
(Date:5/4/2015)... Texas (PRWEB) May 04, 2015 Peacock ... about our mothers. He said, “My mother was the most ... Day, wrap her in lovely, feminine prints and textures ... , Look no further than the Eloise Robe to get ... feel with its cap sleeve and tapered waist. It is ...
Breaking Medicine News(10 mins):Health News:Pricing Healthcare to Pay a Patient's Bill for a Procedure at Utah Facility 2Health News:Pricing Healthcare to Pay a Patient's Bill for a Procedure at Utah Facility 3Health News:New West Medicare Partners with Care to Care, LLC to Manage Advanced Imaging Services 2Health News:Strategic Radiology® Takes Unified Stance Against New USPSTF Guidelines 2Health News:Strategic Radiology® Takes Unified Stance Against New USPSTF Guidelines 3Health News:Strategic Radiology® Takes Unified Stance Against New USPSTF Guidelines 4Health News:Strategic Radiology® Takes Unified Stance Against New USPSTF Guidelines 5Health News:Scanmarket Selected to Spend Matters "50 To Know" List of Companies in Procurement Sector. 2Health News:Feminine Classics for Mother's Day Gifts from Peacock Alley 2
... The director of the Planned Parenthood abortion center in ... worked at the clinic for eight years, but departed from ... The Planned Parenthood clinic was the location of the first-ever ... and the prayer and fasting initiative has been held outside ...
... study of various smoking-cessation aids , MONDAY, Nov. 2 ... quit-smoking products finds that a nicotine patch combined with ... than other methods, including antidepressants, this combination best mimics ... smokers kick their habit, experts said. , "The ...
... new study compares neighborhoods, walkability (degree of ease for ... that some neighborhoods might be good for walking, but ... include University of Minnesota faculty member Julian Marshall and ... Frank. The findings highlight the need for urban ...
... between diagnosis and therapy, study finds , MONDAY, Nov. 2 ... to wait between lung cancer diagnosis and treatment is influenced ... study finds. , Researchers at the University of Texas Southwestern ... cell lung cancer. , They found that factors such as ...
... Nov. 2 Cumberland Pharmaceuticals Inc. (Nasdaq: ... care and gastroenterology markets, today announced that Chief Executive Officer ... present an update on the company at the Lazard Healthcare ... Tuesday, November 17, 2009. , The presentation will be ...
... HOUSTON, Nov. 2 Service Corporation International (NYSE: SCI ) announced ... third quarter 2009 on Wednesday, November 4, 2009, after the market closes. ... November 5, 2009. Details of the conference call are as follows: ... International Third Quarter 2009 Earnings, ...
Cached Medicine News:Health News:Planned Parenthood Director Quits Abortion Business, Experiences Conversion at Starting Place of 40 Days for Life 2Health News:Nicotine Patch Plus Lozenge Best for Quitting Smoking 2Health News:Nicotine Patch Plus Lozenge Best for Quitting Smoking 3Health News:Researchers discover links between city walkability and air pollution exposure 2Health News:Researchers discover links between city walkability and air pollution exposure 3Health News:Service Corporation International Announces Schedule for Its Third Quarter 2009 Earnings Release and Conference Call 2
(Date:5/4/2015)... FRAMINGHAM, Mass. , May 4, 2015   HeartWare ... of less invasive, miniaturized circulatory support technologies that are revolutionizing ... and CEO, Doug Godshall , is scheduled to present ... Conference in Las Vegas on Thursday, ... The live webcast of the Company,s presentation at ...
(Date:5/4/2015)... CARLSBAD, Calif. , May 4, 2015  Isis ... an exclusive license agreement with Bayer HealthCare (Bayer) to ... of thrombosis. Under the terms of the agreement, Isis ... near-term payments, including an immediate $100 million up-front payment ... program following a Phase 2 study in patients with ...
(Date:5/4/2015)... , May 4, 2015 MEI Pharma, ... focused on the clinical development of novel therapies ... mitochondria-specific effects of the Company,s investigational drug candidate ... activity when combined with a tyrosine-kinase inhibitor (TKI). ... to be a potent inhibitor of mitochondrial oxidative ...
Breaking Medicine Technology:HeartWare Presentation At Bank Of America Merrill Lynch 2015 Health Care Conference To Be Webcast 2Isis Pharmaceuticals Licenses ISIS-FXI Rx to Bayer to Develop and Commercialize for the Prevention of Thrombosis 2Isis Pharmaceuticals Licenses ISIS-FXI Rx to Bayer to Develop and Commercialize for the Prevention of Thrombosis 3Isis Pharmaceuticals Licenses ISIS-FXI Rx to Bayer to Develop and Commercialize for the Prevention of Thrombosis 4Isis Pharmaceuticals Licenses ISIS-FXI Rx to Bayer to Develop and Commercialize for the Prevention of Thrombosis 5MEI Pharma's Mitochondrial Inhibitor ME-344 Shows Enhanced Anti-Tumor Activity in Combination with Tyrosine-Kinase Inhibitor in Pre-Clinical Studies 2MEI Pharma's Mitochondrial Inhibitor ME-344 Shows Enhanced Anti-Tumor Activity in Combination with Tyrosine-Kinase Inhibitor in Pre-Clinical Studies 3MEI Pharma's Mitochondrial Inhibitor ME-344 Shows Enhanced Anti-Tumor Activity in Combination with Tyrosine-Kinase Inhibitor in Pre-Clinical Studies 4MEI Pharma's Mitochondrial Inhibitor ME-344 Shows Enhanced Anti-Tumor Activity in Combination with Tyrosine-Kinase Inhibitor in Pre-Clinical Studies 5
... 27 Due to rising patient responsibility for ... state laws requiring disclosure of information on hospital charges, ... estimates for healthcare services. Competitive hospitals also realize they ... accountability to key stakeholders, protect against compliance risks, focus ...
... , , ... 280,000 external defibrillators used worldwide in health care facilities, public places, or in the home ... Drug Administration warned today. , , , ... , , , ...
Cached Medicine Technology:Craneware Shares Patient Estimation Revenue Integrity Insights 2Craneware Shares Patient Estimation Revenue Integrity Insights 3Craneware Shares Patient Estimation Revenue Integrity Insights 4FDA Warns Users About Faulty Components in 14 External Defibrillator Models 2FDA Warns Users About Faulty Components in 14 External Defibrillator Models 3
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: